Osteochondrosis in Yearlings and Future Racing Performance

The number and severity of lesions present could impact a horse’s future racing performance.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

Osteochondrosis—one of the most common forms of developmental orthopedic disease—in young Thoroughbreds can be directly linked to racing performance later in life, according to recent study results from a team of French equine orthopedics authorities.

The researchers found that the type and location of juvenile osteochondral condition (JOCC) lesions can affect when those horses race, how well they race, how long they’ll race, and if they’ll even end up racing at all, said Céline Robert, PhD, DVM, lecturer and researcher at the French National Veterinary School of Alfort in Maisons-Alfort. The lesions’ effect on performance is closely linked to their number and severity, Robert warned.

“Buyers (and especially advising veterinarians) should take into consideration not only the number of visible lesions in all radiographic images but also the severity of those lesions,” she said. “A single, isolated lesion that’s not very severe will probably have no influence on the horse’s career. By contrast, however, a serious lesion or the presence of several lesions could limit the horse’s career.”

Robert and colleagues followed the racing performances of 328 Thoroughbreds radiographed as yearlings; They found that those horses with the most JOCC lesions and those with the most severe JOCC lesions tended to start racing late, stop racing early, or not race at all, Robert said

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Passionate about horses and science from the time she was riding her first Shetland Pony in Texas, Christa Lesté-Lasserre writes about scientific research that contributes to a better understanding of all equids. After undergrad studies in science, journalism, and literature, she received a master’s degree in creative writing. Now based in France, she aims to present the most fascinating aspect of equine science: the story it creates. Follow Lesté-Lasserre on Twitter @christalestelas.

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

What do you think: Can pituitary pars intermedia dysfunction (PPID) be managed by medication alone?
126 votes · 126 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!